Visit COVID-19 resources

[Skip to Content]

Immune reconstitution after alemtuzumab therapy for multiple sclerosis triggering Graves’ orbitopathy: a case series – (Immune reconstitution after alemtuzumab therapy for multiple sclerosis triggering Graves’ orbitopathy: a case series, Published online: 2018-11-29; | doi:10.1038/s41433-018-0282-1)

29 November 2018

This news item is available to RCOphth members only, please log in below to access.

Members Login